Frontier Biosolutions, our new global pharma services platform, will invest in a portfolio of companies focused on specialized pharmaceutical services to advanced therapeutics customers. It’s first investment: Coriolis Pharma.
📺 to learn more: go.kkr.com/3Qij0sX
Oct 16, 2023 · 3:10 PM UTC
